OPENACT: PHASE 2, OPEN-LABEL STUDY OF SIPULEUCEL-T IN METASTATIC CASTRATE-RESISTANT PROSTATE CANCER (MCRPC)

被引：0
作者：
Corman, J. [1 ]
Dawson, N. [2 ]
Hall, S. [3 ]
Nabhan, C. [4 ]
Ferrari, A. [5 ]
Armstrong, A. J. [6 ]
Murdock, M. I. [7 ]
Stewart, F. [8 ]
Sheikh, N. [9 ]
Petrylak, D. P. [10 ]
机构：
[1] Virginia Mason Med Ctr, Seattle, WA 98101 USA
[2] Georgetown Univ, Washington, WA USA
[3] Mt Sinai Sch Med, New York, NY USA
[4] Advocate Lutheran Gen Hosp, Park Ridge, IL USA
[5] NYU, Ctr Canc, New York, NY USA
[6] Duke Univ, Duke Canc Inst, Durham, NC USA
[7] Murdock Urol Associates, Urol, Greenbelt, MD USA
[8] Dendreon Corp, Biometr, Seattle, WA USA
[9] Dendreon Corp, Clin Immunol, Seattle, WA USA
[10] Columbia Univ, Med Ctr, New York, NY USA
来源：
ANNALS OF ONCOLOGY | 2012年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：311 / 311
页数：1
相关论文
共 50 条
[21]   SIPULEUCEL-T IN AFRICAN AMERICANS: A SUBGROUP ANALYSIS OF THREE PHASE 3 TRIALS OF SIPULEUCEL-T IN METASTATIC CASTRATE RESISTANT PROSTATE CANCER [J].
McLeod, David G. ;
Quinn, David I. ;
Cullen, Jennifer ;
Whitmore, James B. .
JOURNAL OF UROLOGY, 2012, 187 (04) :E388-E388
[22]   Race-Related Differences in Sipuleucel-T Response among Men with Metastatic Castrate-Resistant Prostate Cancer [J].
Heath, Elisabeth I. ;
Thakur, Archana ;
Chen, Wei ;
Hwang, Clara ;
Paller, Channing J. ;
Cackowski, Frank C. ;
Boerner, Julie L. ;
Heilbrun, Lance ;
Smith, Melanie P. ;
Schalk, Dana L. ;
Schienschang, Amy ;
Whitaker, Sarah A. ;
Polend, Amanda ;
Smith, Daryn ;
Vaishampayan, Ulka N. ;
Dickow, Brenda ;
Lum, Lawrence G. .
CANCER RESEARCH COMMUNICATIONS, 2024, 4 (07) :1715-1725
[23]   A comparison of sipuleucel-T (sip-T) product parameters from two phase III studies: PROVENT in active surveillance prostate cancer and IMPACT in metastatic castrate-resistant prostate cancer (mCRPC) [J].
Ross, Ashley ;
Armstrong, Andrew J. ;
Pieczonka, Christopher M. ;
Bailen, James L. ;
Tutrone, Ronald F. ;
Cooperberg, Matthew R. ;
Pavlovich, Christian P. ;
Renzulli, Joseph F. ;
Haynes, Heather ;
Sheikh, Nadeem Anwar ;
Shore, Neal D. .
JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06)
[24]   Complete Biochemical Response (Prostate Specific Antigen) to Sipuleucel-T in Metastatic Castrate-Resistant Prostate Cancer: A Case Report With Docetaxel Chemotherapy Administered Just Before Sipuleucel-T [J].
McNamara, Megan ;
Berry, William .
CLINICAL GENITOURINARY CANCER, 2015, 13 (05) :E361-E364
[25]   Randomized phase II study of sipuleucel-T (SipT) with or without radium-223 (Ra223) in men with asymptomatic bone-metastatic castrate-resistant prostate cancer (mCRPC) [J].
Marshall, Catherine Handy ;
Park, Jong Chul ;
DeWeese, Theodore L. ;
King, Serina ;
Afful, Michaella ;
Hurrelbrink, Julia ;
Manogue, Charlotte ;
Cotogno, Patrick ;
Moldawer, Nancy P. ;
Barata, Pedro C. ;
Drake, Charles G. ;
Posadas, Edwin M. ;
Armstrong, Andrew J. ;
Sartor, A. Oliver ;
Antonarakis, Emmanuel S. .
JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06)
[26]   Sipuleucel-T (Provenge) autologous vaccine approved for treatment of men with asymptomatic or minimally symptomatic castrate-resistant metastatic prostate cancer [J].
Gardner, Thomas A. ;
Elzey, Bennett D. ;
Hahn, Noah M. .
HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2012, 8 (04) :534-539
[27]   Randomized phase II trial of sipuleucel-T immunotherapy preceded by sensitizing radiation therapy and sipuleucel-t alone in patients with metastatic castrate resistant prostate cancer [J].
Twardowski, Przemyslaw ;
Wong, Jeffrey Y. C. ;
Pal, Sumanta K. ;
Frankel, Paul Henry ;
Franklin, Kelly ;
Junqueira, Maribel .
JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (06)
[28]   Development of sipuleucel-T: Autologous cellular immunotherapy for the treatment of metastatic castrate resistant prostate cancer [J].
Sims, Robert B. .
VACCINE, 2012, 30 (29) :4394-4397
[29]   A phase II, multicenter, randomized, open-label study to evaluate the safety and tolerability of proxalutamide (GT0918) in subjects with metastatic castrate-resistant prostate cancer (mCRPC). [J].
Zhou, Tie ;
Ye, Dingwei ;
Sun, Zhongquan ;
Meng, Qinggui ;
He, Dalin ;
Shi, Guowei ;
Jin, Jie ;
Sun, Weibing ;
Chen, Lijun ;
Liu, Ben ;
Wang, Jingen ;
Cheng, Jiwen ;
Hu, Zhiquan ;
Yang, Yong ;
Song, Xishuang ;
Wang, Yinhuai ;
Fu, Cheng ;
Zhou, Qiaoxia ;
Tong, Youzhi ;
Sun, Ying-Hao .
JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (06)
[30]   Time to disease-related pain after sipuleucel-T in asymptomatic patients with metastatic castrate-resistant prostate cancer (mCRPC): Results from three randomized phase III trials [J].
Small, E. J. ;
Higano, C. S. ;
Kantoff, P. W. ;
Whitmore, J. B. ;
Frohlich, M. W. ;
Petrylak, D. P. .
JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
12345